Pancreatic fibrosis and standard diagnostics

Ceyhan G., Friess H.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, vol.12, no.2, pp.69-70, 2015 (SCI-Expanded) identifier identifier identifier


In 2014, pancreatic fibrosis has increasingly been recognized as a key determinant of the pathogenesis, therapy response and disease progression of chronic pancreatitis and pancreatic cancer. In addition, secretin-stimulated magnetic resonance cholangiopancreatography has gained increasing importance, especially in visualizing pancreatic duct abnormalities. However, the true imaging capacity has not been fully analysed.